Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Breast Cancer

Free Subscription Articles published in Carcinogenesis Retrieve available abstracts of 22 articles: HTML format

Single Articles

January 2023
1. 
   Correction to: SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer.
   Carcinogenesis. 2023 Jan 30:bgad002. doi: 10.1093.
   PubMed    
   
   
   November 2022
2. YIN X, Li G, Fan D, Ge Z, et al
   Ehm2 transcript variant 1 inhibits breast cancer progression and increases E-cadherin stability.
   Carcinogenesis. 2022 Nov 24:bgac076. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2022
3. ZHAO L, Lei J, Gu S, Zhang Y, et al
   A yes-associated protein 1-Notch1 positive feedback loop promotes breast cancer lung metastasis by attenuating the Bone morphogenetic protein 4-SMAD family member 1/5 signaling.
   Carcinogenesis. 2022 Oct 4. pii: 6748174. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2022
4. ZHOU LX, Zheng H, Tian Y, Luo KF, et al
   SNCA inhibits epithelial-mesenchymal transition and correlates to favorable prognosis of breast cancer.
   Carcinogenesis. 2022 Sep 30. pii: 6732370. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2022
5. AITMAGAMBETOVA MA, Smagulova GA, Tuhvatshin RR, Zheksenova AN, et al
   Genetic and clinical characteristics of BRCA-associated hereditary breast cancer in the West region of Kazakhstan.
   Carcinogenesis. 2022 Aug 2. pii: 6653490. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2022
6. MOU J, Xu X, Wang F, Kong W, et al
   HMGN4 plays a key role in STAT3-mediate oncogenesis of triple-negative breast cancer.
   Carcinogenesis. 2022 Jul 6. pii: 6632630. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2022
7. 
   Retraction to: 2-Tellurium-bridged beta-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression.
   Carcinogenesis. 2022 Jun 22. pii: 6610927. doi: 10.1093.
   PubMed    
   
   
   
8. SUMAN P, Mehta V, Craig AWB, Chander H, et al
   Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion.
   Carcinogenesis. 2022;43:494-503.
   PubMed     Abstract available
   
   
   May 2022
9. 
   Correction to: tRNA-derived fragment tRFLys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PC.
   Carcinogenesis. 2022 May 31. pii: 6596197. doi: 10.1093.
   PubMed    
   
   
   
10. BICER A, Lopez-Henares P, Feu-Llaurado A, Sabariego M, et al
    The PxIxIT motif of the RCAN3 Inhibits angiogenesis and tumor progression in Triple Negative Breast Cancer in Immunocompetent Mice.
    Carcinogenesis. 2022 May 30. pii: 6594970. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. LI N, Wang X, Sun J, Liu Y, et al
    miR-21-5p/Tiam1-mediated glycolysis reprogramming drives breast cancer progression via enhancing PFKL stabilization.
    Carcinogenesis. 2022 May 2. pii: 6577054. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2022
12. ELISIA I, Yeung M, Wong J, Kowalski S, et al
    A low-carbohydrate diet containing soy protein and fish oil reduces breast but not prostate cancer in C3(1)/Tag mice.
    Carcinogenesis. 2022;43:115-125.
    PubMed     Abstract available
    
    
    January 2022
13. CHEN M, Li S, Srinivasasainagendra V, Sharma M, et al
    Maternal soybean genistein on prevention of later-life breast cancer through inherited epigenetic regulations.
    Carcinogenesis. 2022 Jan 27. pii: 6515999. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2021
14. XU R, Yan Y, Zheng X, Zhang H, et al
    Aspirin Suppresses Breast Cancer Metastasis to Lung by Targeting Anoikis Resistance.
    Carcinogenesis. 2021 Dec 27. pii: 6484923. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. PARK J, Huang D, Chang YJ, Lim MC, et al
    Oral contraceptives and risk of breast cancer and ovarian cancer in women with a BRCA1 or BRCA2 mutation: A meta-analysis of observational studies.
    Carcinogenesis. 2021 Dec 27. pii: 6484912. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. ZENG Q, Jin F, Qian H, Chen H, et al
    The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.
    Carcinogenesis. 2021 Dec 18. pii: 6469523. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. HUANG S, Shu X, Ping J, Wu J, et al
    TBX1 functions as a putative oncogene of breast cancer through promoting cell cycle progression.
    Carcinogenesis. 2021 Dec 17. pii: 6469002. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. SHLIAKHTUNOU YA, Siamionau VM, Pobyarzhin VV
    Transcription phenotype of circulating tumor cells in non-metastatic breast cancer.
    Carcinogenesis. 2021 Dec 17. pii: 6469006. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2021
19. AL-JOMAH N, Al-Mohanna FH, Aboussekhra A
    Tocilizumab suppresses the pro-carcinogenic effects of breast cancer- associated fibroblasts through inhibition of the STAT3/AUF1 pathway.
    Carcinogenesis. 2021 Oct 30. pii: 6414472. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. CHO BA, Iyengar NM, Zhou XK, Morrow M, et al
    Blood biomarkers reflect the effects of obesity and inflammation on the human breast transcriptome.
    Carcinogenesis. 2021;42:1281-1292.
    PubMed     Abstract available
    
    
    
21. GODINA C, Khazaei S, Tryggvadottir H, Visse E, et al
    Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: A prospective cohort study.
    Carcinogenesis. 2021 Oct 4. pii: 6380882. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2021
22. RAHMAN MM, Herath D, Bladen JC, Atkar R, et al
    Differential expression of phosphorylated MEK and ERK correlates with aggressive BCC subtypes.
    Carcinogenesis. 2021;42:975-983.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: